Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Attenuated replication and damaging effects of SARS-CoV-2 Omicron variants in an intestinal epithelial barrier model

Title: Attenuated replication and damaging effects of SARS-CoV-2 Omicron variants in an intestinal epithelial barrier model
Authors: Volčič, Meta; Nchioua, Rayhane; Pastorio, Chiara; Zech, Fabian; Haußmann, Isabell; Sauter, Daniel; Read, Clarissa; Walther, Paul; Kirchhoff, Frank
Publisher Information: Universität Ulm
Publication Year: 2024
Collection: OPARU (OPen Access Repository of Ulm University)
Subject Terms: Gut barrier; Intestinal epithelium model; Omicron; SARS-CoV-2; Tight junctions
Description: Many COVID-19 patients suffer from gastrointestinal symptoms and impaired intestinal barrier function is thought to play a key role in Long COVID. Despite its importance, the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on intestinal epithelia is poorly understood. To address this, we established an intestinal barrier model integrating epithelial Caco-2 cells, mucus-secreting HT29 cells and Raji cells. This gut epithelial model allows efficient differentiation of Caco-2 cells into microfold-like cells, faithfully mimics intestinal barrier function, and is highly permissive to SARS-CoV-2 infection. Early strains of SARS-CoV-2 and the Delta variant replicated with high efficiency, severely disrupted barrier function, and depleted tight junction proteins, such as claudin-1, occludin, and ZO-1. In comparison, Omicron subvariants also depleted ZO-1 from tight junctions but had fewer damaging effects on mucosal integrity and barrier function. Remdesivir, the fusion inhibitor EK1 and the transmembrane serine protease 2 inhibitor Camostat inhibited SARS-CoV-2 replication and thus epithelial barrier damage, while the Cathepsin inhibitor E64d was ineffective. Our results support that SARS-CoV-2 disrupts intestinal barrier function but further suggest that circulating Omicron variants are less damaging than earlier viral strains.
Document Type: article in journal/newspaper
File Description: application/pdf
Language: English
DOI: 10.18725/OPARU-58543
Availability: https://doi.org/10.18725/OPARU-58543; http://nbn-resolving.de/urn:nbn:de:bsz:289-oparu-58618-6
Rights: https://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.2ACE3792
Database: BASE